Breakthrough Type 1 Diabetes Treatment Cures All 12 Trial Participants

A groundbreaking clinical trial at the University of Chicago has potentially cured all 12 participants of Type 1 diabetes. The procedure involves transplanting islet cells onto the pancreas, combined with a new drug to prevent rejection. This development could revolutionize treatment for the disease, which currently requires lifelong insulin management. Type 1 diabetes is an autoimmune condition in which the body attacks insulin-producing cells in the pancreas. The new approach aims to replace these cells and protect them from immune system attack using an innovative immunosuppressive drug. If successful in larger trials, this could eliminate the need for daily insulin injections and improve quality of life for millions. NBC News' Anne Thompson takes a closer look at the science behind the trial, the patients involved, and the potential impact on diabetes care. While further research is needed, the results so far offer unprecedented hope for a cure.